Moderna Inc. buy WatchMen
Start price
16.11.20
/
50%
€74.71
Target price
16.11.21
-
Performance (%)
-
End price
16.11.20
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Moderna Inc. | 0.040% | 0.040% | -18.537% | -77.405% |
iShares Core DAX® | 2.687% | -4.620% | 11.789% | 9.959% |
iShares Nasdaq 100 | 5.569% | -7.315% | 24.297% | 36.179% |
iShares Nikkei 225® | 3.756% | -7.813% | 10.017% | 3.466% |
iShares S&P 500 | 3.959% | -3.697% | 21.637% | 35.681% |
According to WatchMen what are the pros and cons of Moderna Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small Risks for its business
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons
Comments by WatchMen for this prediction
In the thread Moderna Inc. diskutieren
Buy Moderna Inc.
In the thread Trading Moderna Inc.
Buy beendet
Current prediction by WatchMen for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€97.01
24.03.24
24.03.24
€130.00
24.03.25
24.03.25
-22.99%
14.08.24
14.08.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Stopped prediction by WatchMen for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€126.14
21.02.22
21.02.22
-
21.02.23
21.02.23
19.31%
22.02.23
22.02.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Moderna Inc.
Start price
Target price
Perf. (%)
€91.45
25.11.20
25.11.20
€180.00
25.11.21
25.11.21
161.40%
26.11.21
26.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Moderna Inc.
Start price
Target price
Perf. (%)
€80.67
16.11.20
16.11.20
-
16.11.21
16.11.21
0.36%
16.11.20
16.11.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected